Insider Buying: Avantor, Inc. (NYSE:AVTR) Director Purchases 25,000 Shares of Stock

Avantor, Inc. (NYSE:AVTR) Director Gregory L. Summe acquired 25,000 shares of Avantor stock in a transaction on Wednesday, May 7th. The shares were bought at an average price of $12.00 per share, with a total value of $300,000.00. Following the completion of the transaction, the director now directly owns 50,000 shares of the company’s stock, valued at $600,000. This trade represents a 100.00% increase in their position. The acquisition was disclosed in a legal filing with the SEC, which is available at this hyperlink.

Avantor Stock Performance

Avantor stock opened at $12.03 on Monday. The firm has a 50 day simple moving average of $15.13 and a 200-day simple moving average of $18.89. The stock has a market cap of $8.20 billion, a price-to-earnings ratio of 11.57, a price-to-earnings-growth ratio of 1.55 and a beta of 1.09. The company has a debt-to-equity ratio of 0.54, a current ratio of 1.07 and a quick ratio of 0.70. Avantor, Inc. has a 1-year low of $11.82 and a 1-year high of $28.00.

Avantor (NYSE:AVTR) last posted its earnings results on Friday, April 25th. The company reported $0.23 earnings per share (EPS) for the quarter, hitting the consensus estimate of $0.23. Avantor had a return on equity of 12.17% and a net margin of 10.49%. The company had revenue of $1.58 billion during the quarter, compared to analysts’ expectations of $1.61 billion. During the same quarter last year, the firm earned $0.22 earnings per share. The firm’s quarterly revenue was down 5.9% compared to the same quarter last year. On average, analysts expect that Avantor, Inc. will post 1.06 EPS for the current year.

Analyst Ratings Changes

AVTR has been the subject of several research analyst reports. Robert W. Baird reduced their price target on shares of Avantor from $21.00 to $17.00 and set an “outperform” rating for the company in a research report on Monday, April 28th. Barclays lowered their price target on Avantor from $18.00 to $15.00 and set an “overweight” rating on the stock in a research note on Monday, April 28th. TD Cowen downgraded Avantor from a “buy” rating to a “hold” rating and set a $15.50 price objective for the company. in a research note on Monday, April 28th. Citigroup lowered their target price on shares of Avantor from $22.00 to $18.00 and set a “neutral” rating on the stock in a research note on Tuesday, March 4th. Finally, The Goldman Sachs Group cut shares of Avantor from a “buy” rating to a “neutral” rating and reduced their target price for the company from $23.00 to $14.00 in a research report on Tuesday, April 29th. Seven research analysts have rated the stock with a hold rating and six have issued a buy rating to the stock. According to data from MarketBeat.com, the stock has a consensus rating of “Hold” and an average price target of $18.88.

Institutional Trading of Avantor

Several institutional investors and hedge funds have recently bought and sold shares of the stock. Louisiana State Employees Retirement System raised its stake in shares of Avantor by 0.3% in the 4th quarter. Louisiana State Employees Retirement System now owns 188,900 shares of the company’s stock valued at $3,980,000 after acquiring an additional 500 shares during the period. Blue Trust Inc. lifted its stake in Avantor by 6.9% during the fourth quarter. Blue Trust Inc. now owns 8,069 shares of the company’s stock worth $170,000 after purchasing an additional 522 shares in the last quarter. Pacer Advisors Inc. boosted its position in shares of Avantor by 0.5% during the fourth quarter. Pacer Advisors Inc. now owns 99,825 shares of the company’s stock worth $2,103,000 after buying an additional 542 shares during the period. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. grew its stake in shares of Avantor by 10.5% in the fourth quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 6,257 shares of the company’s stock valued at $132,000 after buying an additional 592 shares in the last quarter. Finally, MassMutual Private Wealth & Trust FSB grew its stake in shares of Avantor by 99.5% in the fourth quarter. MassMutual Private Wealth & Trust FSB now owns 1,253 shares of the company’s stock valued at $26,000 after buying an additional 625 shares in the last quarter. 95.08% of the stock is currently owned by hedge funds and other institutional investors.

Avantor Company Profile

Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.